Skin Analytics uses artificial intelligence to screen for melanoma skin cancer.
Skin Analytics has raised €22M across 2 funding rounds from 2 investors, most recently a Series B round in Apr 2025. Based in London, UK; founded 2012; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-04-16 | Series B | €18M | Intrepid Partners | View deal → |
| 2020-09-08 | Series A | €4.5M | Hoxton Ventures | View deal → |
